Bio-Rad Laboratories | BIO - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Abbott USD 297M 2M 2026-09
Agilent USD 29M 4M 2026-06
Becton, Dickinson and Co. USD 130M 2M 2026-09
Bio Techne USD 2.17M 1.43M 2026-09
Bio-Rad Laboratories USD 12.1M 200K 2026-06
Bruker USD 17.8M 9.7M 2026-06
Charles River Laboratories USD 28.52M 1.82M 2026-09
Danaher USD 135M 28M 2026-09
General Electric Aerospace USD 231M 265M 2026-09
Illumina USD 24M 0 2026-09
IQVIA Holdings USD 203M 6M 2026-09
Laboratory Of America USD 59.1M 2M 2026-09
Merck USD 525M 46M 2026-06
Mettler Toledo International USD 15.68M 1.57M 2026-09
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Quest Diagnostics USD 61M 8M 2026-09
Repligen USD 5.71M 49K 2026-09
Revvity USD 20.81M 2.18M 2026-09
Roche Holding CHF 304M 7.5M 2025-06
Siemens EUR 371M 64M 2026-06
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 417M 63M 2026-09
Tosoh JPY 884M 65M 2025-09
Waters USD 53M 2M 2026-09